Cite
MLA Citation
Philip J. Mease et al.. “FRI0451 SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS IN PSORIATIC ARTHRITIS: FINAL 5 YEAR EFFICACY AND SAFETY RESULTS FROM A PHASE 3 TRIAL.” Annals of the rheumatic diseases, vol. 78, n.d., p. 917. http://access.bl.uk/ark:/81055/vdc_100144716787.0x00005c